arrow
S

Stefan Delorme

Helmholtz Association
H指数:65
被引数:1.4万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Automated radiomics model for prediction of therapy response and minimal residual disease from baseline MRI in multiple myeloma

基于基线MRI的自动放射组学模型,用于预测多发性骨髓瘤的治疗反应和微小残留病灶

2025-10-100
OA
Validation of novel low-dose CT methods for quantifying bone marrow in the appendicular skeleton of patients with multiple myeloma: initial results from the [18F]FDG PET/CT sub-study of the Phase 3 GMMG-HD7 Trial

验证用于量化多发性骨髓瘤患者四肢骨骼骨髓的新型低剂量CT方法:来自Phase 3 GMMG-HD7试验[18F]FDG PET/CT亚研究的初步结果

2025-10-010
OA
Automated Detection of Focal Bone Marrow Lesions From MRI: A Multi-center Feasibility Study in Patients with Monoclonal Plasma Cell Disorders

基于MRI的局灶性骨髓病变自动检测:一项在单克隆浆细胞疾病患者中的多中心可行性研究

2025-07-090
OAAI
Nivolumab and ipilimumab in recurrent or refractory cancer of unknown primary: a phase II trial
2023-10-2416
OAAI
Prediction of Bone Marrow Biopsy Results From MRI in Multiple Myeloma Patients Using Deep Learning and Radiomics

使用深度学习和放射组学预测多发性骨髓瘤患者MRI的骨髓活检结果

2023-05-2212
PRE
Deep Learning for Automatic Bone Marrow Apparent Diffusion Coefficient Measurements From Whole-Body Magnetic Resonance Imaging in Patients With Multiple Myeloma A Retrospective Multicenter Study
2022-10-0314
PRE
In Vivo Repeatability and Multiscanner Reproducibility of MRI Radiomics Features in Patients With Monoclonal Plasma Cell Disorders A Prospective Bi-institutional Study
2022-09-1624
PRE
Combining Deep Learning and Radiomics for Automated, Objective, Comprehensive Bone Marrow Characterization From Whole-Body MRI A Multicentric Feasibility Study
2022-05-2725
PRE
Repeatability and Reproducibility of ADC Measurements and MRI Signal Intensity Measurements of Bone Marrow in Monoclonal Plasma Cell Disorders A Prospective Bi-institutional Multiscanner, Multiprotocol Study
2021-11-2430
PRE
Validation of multivariable lung cancer risk prediction models for the personalized assignment of optimal screening frequency: a retrospective analysis of data from the German Lung Cancer Screening Intervention Trial (LUSI)

验证多变量肺癌风险预测模型对最佳筛查频率的个性化分配: 对德国肺癌筛查干预试验 (LUSI) 数据的回顾性分析

2021-03-017
OAAI